The cluster of open-market sales by the CEO, President, and two other C-suite officers, without any disclosed 10b5-1 plans, is a strong negative signal. Monitor for any upcoming clinical data readouts or corporate developments that may have prompted this coordinated selling.
Price Chart
Executive Summary
Five Pharvaris insiders, including the CEO, President, and Chief Commercial Officer, collectively sold $2.93M in open-market stock over a one-week window. The sales are concentrated and material relative to the company's market cap, signaling a bearish read-through despite the absence of a disclosed negative catalyst.
Key Financial Metrics
Key Facts
- Five insiders sold a total of $2.93M in open-market shares between Sept 7-14, 2026.
- CEO Berndt Modig sold $90K; President Lu Peng sold $602K; Chief Commercial Officer Wim Souverijns sold $786K; Chief Early Development Anne Lesage sold $1.15M; Director Robert Glassman sold $300K.
- President Lu Peng's sale followed a derivative exercise at $2.59/share, realizing a large gain.
- Chief Early Development Anne Lesage's sale followed derivative exercises at $0 and $8.05/share.
- No 10b5-1 plan indications were noted for the open-market sales.
- The total open-market sale value of $2.93M represents approximately 0.9% of the company's $326M market cap.
Financial Impact
Insider selling of $2.93M (0.9% of market cap) concentrated among top executives.
Risk Factors
- Insider selling may indicate management's lack of confidence in near-term prospects.
- Potential negative clinical or regulatory catalyst not yet disclosed to the market.
- Further insider selling could pressure the stock.
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-PHVS-1789582050282 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 25, 2026 4w ago | Insider Cluster | $32.02 $31.19 | ▲ +2.59% | ▲ +2.37% | $31.95 (+0.22%) |
Sep 24, 2026 4w ago | Insider Cluster | $32.99 $31.01 | ▲ +6.00% | ▲ +5.59% | $31.95 (+3.15%) |
Sep 24, 2026 4w ago | Insider Cluster | $32.99 $31.01 | ▲ +6.00% | ▲ +5.59% | $31.95 (+3.15%) |
Sep 23, 2026 4w ago | Insider Cluster | $33.07 $31.72 | ▲ +4.08% | ▲ +3.41% | $31.95 (+3.39%) |
Sep 21, 2026 5w ago | Insider Cluster | $36.02 $31.91 | ▲ +11.41% | ▲ +10.39% | $31.95 (+11.30%) |
Sep 17, 2026 5w ago | 144 | $36.37 $32.02 | ▲ +11.96% | ▲ +13.23% | $31.95 (+12.15%) |
Sep 17, 2026 5w ago | Insider Cluster | $38.00 $32.99 | ▲ +13.18% | ▲ +13.78% | $31.95 (+15.92%) |
Sep 17, 2026 5w ago | Insider Cluster | $38.00 $32.99 | ▲ +13.18% | ▲ +13.78% | $31.95 (+15.92%) |
Sep 16, 2026 5w ago | Insider Cluster | $37.55 $33.07 | ▲ +11.93% | ▲ +13.76% | $31.95 (+14.91%) |
Sep 15, 2026 6w ago | Insider Cluster | $38.06 $36.37 | ▲ +4.44% | ▲ +5.26% | $31.95 (+16.05%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers